Using a discrete choice experiment (DCE), we explored the relative impacts (i.e. relative preference weights) of different attributes of a genomic test on individuals' decision to use the test for guiding cancer treatment.
Test. is a nation-wide campaign to educate patients, physicians, and caregivers on the new science of comprehensive genomic testing of cancer tumors, but also personalized medicine and how it leads to tailored treatments for those with the disease.
Advances in molecular and genomic testing for patients with suspected infectious diarrhoea are on the horizon.
Genomic testing to point out any hidden genetic risks of atherosclerosis, hypertension and coronary artery disease.
Implications of personal genomic testing for health behaviors: the case of smoking.
The increasing availability of laboratory diagnosis by polymerase chain reaction has opened up new possibilities for genomic testing based on the use of genetic signatures, in routine clinical conditions.
However, due to the lack of standard protocols or accepted patient educational materials for genetic and genomic testing, and depending on the provider and their access to genetics experts, the extent of pre-test communication provision may vary widely.
Patients were generally satisfied with the information they received about recurrence risk based on genomic testing.
There remains significant concern about the impact of genomic test results on a patient's health insurance and perhaps even employment, despite the passage of the Genetic Information and Nondiscrimination Act.
